Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 80-84 , 10 December 2009

Conversion of peripheral CD4+CD25− T cells to CD4+CD25+ regulatory T cells by IFN-γ in patients with Guillain-Barré syndrome

Received 11 August 2009 ,Revised 27 September 2009 ,Accepted 2 October 2009.

References 

  1. Anderson AE, Isaacs JD. Tregs and rheumatoid arthritis. Acta Reumatol. Port. 2008;33(1):17–33
  2. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 1990;27 Suppl:S21–24
  3. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001;167:1245–1253
  4. Chi LJ, Wang HB, Zhang Y, Wang WZ. Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain-Barré syndrome. J. Neuroimmunol. 2007;192(1–2):206–214
  5. Chi LJ, Wang HB, Wang WZ. Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 2008;13(1):54–63
  6. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 2005;6(4):331–337
  7. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, et al. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 2001;56(6):758–765
  8. Hong J, Leonard C. Regulation of immune responses by T cells. N. Engl. J. Med. 2006;354:1166–1176
  9. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057–1061
  10. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 1999;100(1–2):74–97
  11. Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 2005;202(10):1375–1386
  12. Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM. Conversion of CD4+CD25− cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 2005;201(1):127–137
  13. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.. J. Immunol. 1995;155(3):1151–1164
  14. Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25−CD4+ precursors. J. Immunol. 2005;175(9):6107–6116
  15. Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, et al. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation. 2009;87(2):198–206
  16. Van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome Dutch Guillain-Barré Study Group. N. Engl. J. Med. 1992;326(17):1123–1129
  17. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004;199:971–979
  18. Wang ZJ, Hong J, Sun W, Xu G, Li N, Chen X, et al. Role of IFN-gamma in induction of FoxP3 and conversion of CD4+CD25− T cells to CD4+ Tregs. J. Clin. Invest. 2006;116(9):2434–2441
  19. Wang W, Milani M, Ostlie N, Okita D, Agarwal RK, Caspi RR, et al. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-γ are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells. J. Immunol. 2007;178(11):7072–7080
  20. Wang J, van Dongen H, Scherer HU, Huizinga TW, Toes RE. Suppressor activity among CD4+CD25+ T cells is discriminated by membrane-bound tumor necrosis factor alpha. Arthritis Rheum. 2008;58(6):1609–1618
  21. Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Dysfunctional CD4+CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 2008;58(3):801–812
  22. Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA. Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis. Inflamm. Bowel Dis. 2007;13(2):191–199
  23. Zhang Y, Wang HB, Chi LJ, Wang WZ. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol. Lett. 2009;122(1):52–57
  24. Zheng SG. The critical role of TGF-beta1 in the development of induced Foxp3+ regulatory T cells. Int. J. Clin. Exp. Med. 2008;1(3):192–202
  25. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 2006;176(6):3321–3329

PII: S0165-5728(09)00392-0

doi: 10.1016/j.jneuroim.2009.10.001

Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 80-84 , 10 December 2009

Article Tools

* Image Usage & Resolution